Nachrichten zur Zoetis Inc. Aktie

Zoetis (ZTS) Q3 2025 Earnings Call Transcript

Image source: The Motley Fool.DateTuesday, Nov. 4, 2025 at 8:30 a.m. ETCall participantsChief Executive Officer — Kristin PeckChief Financial Officer…

Zoetis (ZTS) Q3 2024 Earnings Call Transcript

Image source: The Motley Fool.DateMonday, November 4, 2024 at 8:30 a.m. ETCall participantsChief Executive Officer — Kristin PeckChief Financial Officer…

Zoetis (ZTS) Q4 2024 Earnings Call Transcript

Image source: The Motley Fool.DateFeb. 13, 2025, 8:30 a.m. ETCall participantsChief Executive Officer — Kristin PeckChief Financial Officer — Wetteny…

Zoetis (ZTS) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool.DATETuesday, Aug. 5, 2025 at 8:30 a.m. ETCALL PARTICIPANTSChief Executive Officer — Kristin C. PeckChief Financial…

Zoetis (ZTS) Q1 2025 Earnings Call Transcript

Image source: The Motley Fool.DATETuesday, May 6, 2025 at 8:30 a.m. ETCALL PARTICIPANTSChief Executive Officer — Kristin PeckChief Financial Officer…

Zoetis stock hits 52-week low at 113.29 USD

Zoetis stock hits 52-week low at 113.29 USD…

Zoetis shares jump after beating Q4 expectations By Investing.com

Zoetis shares jump after beating Q4 expectations…

Zoetis CEO: Committed to Livestock Category

Kristen Peck, Zoetis CEO, says the company is committed to livestock, achieving its third consecutive year of above-market growth. She…

Zoetis Inc. (ZTS) Discusses R&D Pipeline Progress and Strategic Vision in Animal Health Innovation - Slideshow

…

Lenivia Approval Might Change The Case For Investing In Zoetis (ZTS)

In late November 2025, Zoetis Inc. announced that the European Commission granted marketing authorization for Lenivia® (izenive™), a new monoclonal…

Keybanc starts bullish on Elanco and Zoetis By Investing.com

Keybanc starts bullish on Elanco and Zoetis…

Zoetis gains EMA panel endorsement for Lenivia for osteoarthritis pain in dogs

…

Zoetis stock rises after FDA conditionally approves screwworm drug By Investing.com

Zoetis stock rises after FDA conditionally approves screwworm drug…

Zoetis CEO: Its unclear if animal health will be a part of pharmaceutical tariffs

Kristin Peck, Zoetis CEO, joins Closing Bell: Overtime to discuss Q2 earnings, tariff impact on business and domestic production.…

Animal healthcare firm Zoetis raises annual forecast on strong pet product demand

Zoetis raised annual forecast and beat second-quarter estimates on Tuesday, driven by strong demand for its medicines and vaccines for…

Zoetis Inc earnings beat by $0.14, revenue topped estimates By Investing.com

Zoetis Inc earnings beat by $0.14, revenue topped estimates…

ZTS Q2 Earnings & Revenues Beat Estimates, 25 Outlook Raised

Zoetis posts better-than-expected Q2 results with rising sales of pet medicines, boosting its 2025 outlook.…

3 Magnificent S&P 500 Dividend Stocks Down 19% to 26%: Is It Time to Buy the Dip?

Key PointsThese three dividend growth stocks are the best operators in their respective niches.Each stock has a return on invested…

2 Dividend Growth Stocks to Buy and Hold Forever

Key PointsInvesting in attractive dividend growth stocks can lead to superior long-term returns.The two healthcare companies below generally deliver excellent…

Should You Invest in Zoetis (ZTS) Based on Bullish Wall Street Views?

The average brokerage recommendation (ABR) for Zoetis (ZTS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street…

Top Stock Movers Now: Jabil, Oracle, Zoetis, and More

Key Takeaways U.S. equities rose at midday ahead of the latest announcement from the Federal Reserve, as President Donald Trump…

Top Stock Movers Now: Jabil, Oracle, Zoetis, and More

U.S. equities rose at midday ahead of the latest announcement from the Federal Reserve, as President Donald Trump again called…

Zoetis Stock Rises 13% in a Month: Time to Add to Your Portfolio?

ZTS jumps 13% in a month as strong new product sales, strategic deals, and rising earnings estimates boost investor confidence.…

Zoetis Inc. (ZTS) William Blair 45th Annual Growth Stock Conference (Transcript)

…

Zoetis Inc. (ZTS) Stifel 2025 Jaws & Paws Conference (Transcript)

…

Wall Street Analysts Think Zoetis (ZTS) Could Surge 26.18%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 26.2% in Zoetis (ZTS). While…

4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off

Its always a good time to buy solid dividend stocks, but considering the challenging economic environment, now might be a…

A Once-in-a-Decade Opportunity: 3 Magnificent Stocks Down Between 40% and 73% to Buy Right Now

The S&P 500 has dropped 10% or more nine times since 2010, not including the current sell-off. However, the index…

3 Magnificent Stocks to Buy That Are Near 52-Week Lows

Its been a tough start to 2025 for investors amid concerns regarding the strength of the U.S. economy and uncertainties…

This Magnificent Dividend Stock Has Increased Its Payouts by 500% in 10 Years

There are many dividend stocks on equity markets, but not all are attractive to income investors. Those that go beyond…

Zoetis Stock Is About as Cheap as Its Ever Been. 1 Thing to Know Before You Buy.

Shares in animal pharmaceutical company Zoetis (NYSE: ZTS) have been under a cloud since the release of the companys fourth-quarter…

Should You Bet on PAHC Stock at a Discounted P/E of 10.41X?

PAHCs solid MFA franchise, now bolstered by Zoetis portfolio, makes it a solid investment case. A well-established foothold in key…

Zoetis (ZTS) Laps the Stock Market: Heres Why

Zoetis (ZTS) reachead $170.37 at the closing of the latest trading day, reflecting a +1.87% change compared to its last…

A Once-in-a-Decade Opportunity: 1 Magnificent S&P 500 Dividend Stock Down 36% to Double Up on Right Now

It is a beautiful thing when you find a feel-good stock that offers market-beating potential. A perfect example of this…

Love, Money, and Stocks

In this podcast, Motley Fool host Dylan Lewis and analysts Jason Moser and Emily Flippen break down: The Trade Desks 30%…

Zoetis gets Conditional License for Bird Flu Vaccine

Zoetis has been granted a conditional license from the USDA for its avian flu vaccine. Since February 2022, more than…

Why Zoetis Stock Took Another Tumble Today

One day after unveiling quarterly results that disappointed the market and engendered a stock sell-off, Zoetis (NYSE: ZTS) shares again…

Zoetis gains conditional license for avian flu vaccine in chickens

…

Why Zoetis Stock Was Falling Today

Shares of Zoetis (NYSE: ZTS), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up short…

Zoetis: Tiergesundheitsriese enttäuscht – Aktie sackt ab

Der führende Hersteller von Veterinärpharmazeutika, der US-Konzern Zoetis, hat mit den Zahlen zum vierten Quartal die Erwartungen der Analysten zwar…

Zoetis: Tiergesundheitsriese enttäuscht – Aktie sackt ab

Der führende Hersteller von Veterinärpharmazeutika, der US-Konzern Zoetis, hat mit den Zahlen zum vierten Quartal die Erwartungen der Analysten zwar…

Zoetis Aktie: Schwacher Ausblick belastet - Kurs bricht ein

Kulmbach (www.aktiencheck.de) - Zoetis-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Looking to Grow Your Passive Income in 2025? 3 Top Dividend Growth Stocks to Double Up On Right Now

Theres no way around it. Im approaching the age of 40 faster than Id like. Despite this undeniable fact, locating…

Wafaa Mamilli To Join Roche As Chief Digital Technology Officer

Wafaa Mamilli will join Roche as the companys new Chief Digital Technology Officer in February. This follows expansive roles she…

Zoetis stands out in weak animal health sector, Piper survey shows By Investing.com

Zoetis stands out in weak animal health sector, Piper survey shows…

Zoetis CEO Says Its Arthritis Drug for Dogs Is Safe

Zoetis CEO Kristen Peck talks about expanding their line of medications and she says the market for animal care products…

5 Magnificent Dividend Growth Stocks Down 24% to 41% to Buy Before 2025 for a Lifetime of Passive Income

If youre an investor looking to grow your long-term passive income prospects, the five stocks in this article could be…

A Once-in-a-Decade Opportunity: 2 Magnificent S&P 500 Stocks Down 37% and 28% to Buy Before 2025

One of my favorite ways to add money to my portfolio is to invest in proven compounders with track…

Zoetis Inc. (ZTS) Piper Sandler 36th Annual Healthcare Conference (Transcript)

…

Zoetis Inc. (ZTS) Management presents at Jefferies London Healthcare Conference (Transcript)

…